Feasibility and Acceptability of Using Low-Gain Hearing Aids for Bothersome Tinnitus

N/A

Waitlist Available

Led By Tara Zaugg, AuD

Research Sponsored by VA Office of Research and Development

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up the tinnitus functional index will be administered at baseline, 2-3 weeks after baseline, and 3 months after baseline

Awards & highlights

No Placebo-Only Group

Summary

This trial aims to see if hearing aids that provide low-level sound can help Veterans with normal hearing who suffer from bothersome tinnitus. The idea is that amplifying background sounds might make the tinnitus less noticeable. Using hearing aids may help by making the tinnitus less noticeable and improving communication. The study will test this on 20 Veterans to support a larger future study.

Eligible Conditions

Tinnitus
Hearing Aids
Normal Hearing

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ the tinnitus functional index will be administered at baseline, 2-3 weeks after baseline, and 3 months after baseline

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~the tinnitus functional index will be administered at baseline, 2-3 weeks after baseline, and 3 months after baseline

This trial's timeline: 3 weeks for screening, Varies for treatment, and the tinnitus functional index will be administered at baseline, 2-3 weeks after baseline, and 3 months after baseline for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.

Primary study objectives

Tinnitus Functional Index Change

Awards & Highlights

No Placebo-Only Group

All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: Hearing Aid StudyExperimental Treatment1 Intervention

Measure the reduction in tinnitus handicap when mild amplification through receiver-in-the-canal hearing aids is provided to adults with bothersome tinnitus and normal hearing thresholds.

Group II: VA Clinician InterviewsActive Control1 Intervention

Document the opinions, procedures, and rationale used clinically to make decisions regarding fitting mild amplification for tinnitus on Veterans with bothersome tinnitus and normal hearing thresholds. The data for this arm of the study will be collected via telephone interview.

Treatment

First Studied

Drug Approval Stage

How many patients have taken this drug

Receiver in the canal (RIC) hearing aids

2020

N/A

~70

Do I qualify?Apply below to find out